CENTRAL PLAINS BANCSHARES IN (CPBI) Stock Fundamental Analysis

NASDAQ:CPBI • US15486W1009

17.71 USD
+0.01 (+0.06%)
Last: Feb 17, 2026, 08:07 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

CPBI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 381 industry peers in the Banks industry. CPBI may be in some trouble as it scores bad on both profitability and health. CPBI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CPBI had positive earnings in the past year.
  • In the past year CPBI had a positive cash flow from operations.
CPBI Yearly Net Income VS EBIT VS OCF VS FCFCPBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 5M 10M

1.2 Ratios

  • With a Return On Assets value of 0.72%, CPBI is not doing good in the industry: 65.09% of the companies in the same industry are doing better.
  • The Return On Equity of CPBI (4.26%) is worse than 80.31% of its industry peers.
  • CPBI has a better Return On Invested Capital (2.04%) than 98.95% of its industry peers.
  • CPBI had an Average Return On Invested Capital over the past 3 years of 1.59%. This is in line with the industry average of 2.69%.
  • The last Return On Invested Capital (2.04%) for CPBI is above the 3 year average (1.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.72%
ROE 4.26%
ROIC 2.04%
ROA(3y)0.64%
ROA(5y)N/A
ROE(3y)4.48%
ROE(5y)N/A
ROIC(3y)1.59%
ROIC(5y)N/A
CPBI Yearly ROA, ROE, ROICCPBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 2 4 6 8

1.3 Margins

  • The Profit Margin of CPBI (13.47%) is worse than 79.53% of its industry peers.
  • In the last couple of years the Profit Margin of CPBI has declined.
  • Looking at the Operating Margin, with a value of 46.71%, CPBI belongs to the top of the industry, outperforming 99.48% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CPBI has grown nicely.
Industry RankSector Rank
OM 46.71%
PM (TTM) 13.47%
GM N/A
OM growth 3Y13.61%
OM growth 5YN/A
PM growth 3Y-13.12%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CPBI Yearly Profit, Operating, Gross MarginsCPBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CPBI is destroying value.
  • Compared to 1 year ago, CPBI has more shares outstanding
  • CPBI has a worse debt/assets ratio than last year.
CPBI Yearly Shares OutstandingCPBI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 1M 2M 3M 4M
CPBI Yearly Total Debt VS Total AssetsCPBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of -0.56, we must say that CPBI is in the distress zone and has some risk of bankruptcy.
  • CPBI's Altman-Z score of -0.56 is amongst the best of the industry. CPBI outperforms 98.95% of its industry peers.
  • A Debt/Equity ratio of 4.84 is on the high side and indicates that CPBI has dependencies on debt financing.
  • The Debt to Equity ratio of CPBI (4.84) is worse than 95.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.84
Debt/FCF N/A
Altman-Z -0.56
ROIC/WACC0.52
WACC3.92%
CPBI Yearly LT Debt VS Equity VS FCFCPBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • CPBI has a Current Ratio of 0.03. This is a bad value and indicates that CPBI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CPBI has a Current ratio of 0.03. This is amongst the best in the industry. CPBI outperforms 98.95% of its industry peers.
  • A Quick Ratio of 0.03 indicates that CPBI may have some problems paying its short term obligations.
  • CPBI's Quick ratio of 0.03 is amongst the best of the industry. CPBI outperforms 98.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
CPBI Yearly Current Assets VS Current LiabilitesCPBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • CPBI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.43%.
  • CPBI shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.00% yearly.
  • The Revenue has grown by 11.34% in the past year. This is quite good.
  • The Revenue has been growing by 20.93% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)3.43%
EPS 3Y8%
EPS 5YN/A
EPS Q2Q%-7.03%
Revenue 1Y (TTM)11.34%
Revenue growth 3Y20.93%
Revenue growth 5YN/A
Sales Q2Q%10.65%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CPBI Yearly Revenue VS EstimatesCPBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.45, the valuation of CPBI can be described as rather expensive.
  • Based on the Price/Earnings ratio, CPBI is valued a bit more expensive than the industry average as 79.79% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Earnings ratio of 27.16, CPBI is valued a bit cheaper.
Industry RankSector Rank
PE 18.45
Fwd PE N/A
CPBI Price Earnings VS Forward Price EarningsCPBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CPBI is valued cheaper than 99.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.54
CPBI Per share dataCPBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CPBI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CENTRAL PLAINS BANCSHARES IN

NASDAQ:CPBI (2/17/2026, 8:07:22 PM)

17.71

+0.01 (+0.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners27.46%
Inst Owner Change4.12%
Ins Owners9.81%
Ins Owner Change0%
Market Cap74.56M
Revenue(TTM)27.25M
Net Income(TTM)3.67M
AnalystsN/A
Price TargetN/A
Short Float %0.14%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.45
Fwd PE N/A
P/S 2.74
P/FCF N/A
P/OCF 19.68
P/B 0.87
P/tB 0.87
EV/EBITDA 5.54
EPS(TTM)0.96
EY5.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)0.9
OCFY5.08%
SpS6.47
BVpS20.47
TBVpS20.37
PEG (NY)N/A
PEG (5Y)N/A
Graham Number21.03
Profitability
Industry RankSector Rank
ROA 0.72%
ROE 4.26%
ROCE 13.1%
ROIC 2.04%
ROICexc 2.07%
ROICexgc 2.09%
OM 46.71%
PM (TTM) 13.47%
GM N/A
FCFM N/A
ROA(3y)0.64%
ROA(5y)N/A
ROE(3y)4.48%
ROE(5y)N/A
ROIC(3y)1.59%
ROIC(5y)N/A
ROICexc(3y)1.66%
ROICexc(5y)N/A
ROICexgc(3y)1.68%
ROICexgc(5y)N/A
ROCE(3y)12.75%
ROCE(5y)N/A
ROICexgc growth 3Y28.59%
ROICexgc growth 5YN/A
ROICexc growth 3Y28.73%
ROICexc growth 5YN/A
OM growth 3Y13.61%
OM growth 5YN/A
PM growth 3Y-13.12%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 4.84
Debt/FCF N/A
Debt/EBITDA 31.1
Cap/Depr 859.64%
Cap/Sales 21.27%
Interest Coverage 1.43
Cash Conversion 28.28%
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z -0.56
F-Score4
WACC3.92%
ROIC/WACC0.52
Cap/Depr(3y)718.14%
Cap/Depr(5y)N/A
Cap/Sales(3y)13.71%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.43%
EPS 3Y8%
EPS 5YN/A
EPS Q2Q%-7.03%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.34%
Revenue growth 3Y20.93%
Revenue growth 5YN/A
Sales Q2Q%10.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.13%
EBIT growth 3Y37.39%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-189.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.88%
OCF growth 3Y-3.23%
OCF growth 5YN/A

CENTRAL PLAINS BANCSHARES IN / CPBI FAQ

What is the ChartMill fundamental rating of CENTRAL PLAINS BANCSHARES IN (CPBI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CPBI.


Can you provide the valuation status for CENTRAL PLAINS BANCSHARES IN?

ChartMill assigns a valuation rating of 1 / 10 to CENTRAL PLAINS BANCSHARES IN (CPBI). This can be considered as Overvalued.


How profitable is CENTRAL PLAINS BANCSHARES IN (CPBI) stock?

CENTRAL PLAINS BANCSHARES IN (CPBI) has a profitability rating of 3 / 10.


What is the valuation of CENTRAL PLAINS BANCSHARES IN based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CENTRAL PLAINS BANCSHARES IN (CPBI) is 18.45 and the Price/Book (PB) ratio is 0.87.


What is the financial health of CENTRAL PLAINS BANCSHARES IN (CPBI) stock?

The financial health rating of CENTRAL PLAINS BANCSHARES IN (CPBI) is 2 / 10.